Industry Insights Logo

Rethinking 340B: Where Compliance Ends and Strategy Begins

SPONSORED CONTENT

Let’s be honest. 340B compliance is demanding. It takes time, coordination, and precision. After more than a decade working in 340B compliance and auditing, I’ve learned it always comes back to one thing: the data.

Where does the data come from? How accurate is

…
Read More »

CBO Report Requested by GOP Congressional Committee Chairs Links 340B Growth to Drug Spending Trends, ACA-Related Changes and Contract Pharmacy Use Expansion

The new Congressional Budget Office report looked at growth in the 340B program between 2010 and 2021.
…
Read More »

Hospital Group Asks FTC, DOJ to Investigate Drugmakers’ Potential ‘Anticompetitive’ Efforts to Impose 340B Rebate Models

The AHA asked federal officials Monday to investigate whether five drugmakers engaged in anticompetitive practices while seeking to implement 340B rebate models.
…
Read More »

South Carolina Congresswoman Honors Health Center and 340B Leader’s Legacy 

U.S. Rep. Sheri Biggs (R-S.C.) touted Sue Veer’s (above) “remarkable career and dedicated leadership” as the president and CEO of Carolina Health Centers in Sept. 4 Congressional Record remarks.
…
Read More »

State Contract Pharmacy Lawsuit Roundup: Updates in Vermont, Oklahoma, Colorado, Rhode Island

Key briefs were filed recently in litigation over state 340B contract pharmacy laws in Vermont, Oklahoma, Colorado and Rhode Island.
…
Read More »

Bipartisan Group of U.S. House Members Urges Colleagues to Sign onto Letter Opposing HHS’ 340B Rebate Pilot

Four members of the U.S. House are asking colleagues to sign onto a letter urging HHS to abandon its 340B rebate pilot program.
A bipartisan group of U.S. House members is circulating a draft letter urging HHS to abandon its controversial 340B rebate pilot program.
…
Read More »

PhRMA Targets 340B Hospitals in Reported ‘Seven Figure’ Ad Campaign—Its ‘Biggest’ 340B Ad Expenditure Yet

PhRMA released a 30-second television spot targeting the 340B program as part of a reported seven-figure campaign that will run in the Washington D.C.-area through the end of 2025.
…
Read More »
Industry Insights Logo

Part 3 of a 4-Part Series: Is In-House Pharmacy Capture the Overlooked Strategy to Growing Your 340B Program?

SPONSORED CONTENT

The 340B program is facing a period of unprecedented change. With the Inflation Reduction Act (IRA) and Medicare’s Maximum Fair Price (MFP) provisions set to take effect in 2026, covered entities can expect significant shifts—most notably, reduced drug

…
Read More »
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

Site Footer Live